Thermogenesis Holdings Inc
OTC:THMO

Watchlist Manager
Thermogenesis Holdings Inc Logo
Thermogenesis Holdings Inc
OTC:THMO
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $1.6k

Net Margin

-181.7%
Current
Declining
by 22.1%
vs 3-y average of -159.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-181.7%
=
Net Income
$-14.8m
/
Revenue
$9.6m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-181.7%
=
Net Income
$-14.8m
/
Revenue
$9.6m

Peer Comparison

Country Company Market Cap Net
Margin
US
Thermogenesis Holdings Inc
F:THR
4m EUR
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.7B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.6B USD
Loading...
US
Stryker Corp
NYSE:SYK
134.5B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.6B USD
Loading...

Market Distribution

Lower than 87% of companies in the United States of America
Percentile
13th
Based on 15 072 companies
13th percentile
-153.6%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Thermogenesis Holdings Inc
Glance View

Market Cap
1.6k USD
Industry
Health Care

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 39 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for large scale cell manufacturing services. The company manufactures and markets three categories of products, Clinical Bio-Banking Applications, Point-of-Care Applications, and Large Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications includes AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Point-of-Care Applications includes PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory useand CAR-TXpress Platform for clinical manufacturing.

THMO Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-181.7%
=
Net Income
$-14.8m
/
Revenue
$9.6m
What is Thermogenesis Holdings Inc's current Net Margin?

The current Net Margin for Thermogenesis Holdings Inc is -181.7%, which is below its 3-year median of -159.6%.

How has Net Margin changed over time?

Over the last 3 years, Thermogenesis Holdings Inc’s Net Margin has increased from -205.8% to -181.7%. During this period, it reached a low of -210.4% on Dec 31, 2023 and a high of -83.9% on Jun 30, 2022.

Back to Top